A detailed history of Israel Englander (Millennium Management LLC) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Millennium Management LLC holds 693,800 shares of BMY stock, worth $40.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
693,800
Previous 610,700 13.61%
Holding current value
$40.8 Million
Previous $25.4 Million 41.57%
% of portfolio
0.02%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $147 Million - $191 Million
3,694,795 Added 247.87%
5,185,435 $268 Million
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $59.5 Million - $78.3 Million
1,477,680 Added 11401.85%
1,490,640 $61.9 Million
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $119 Million - $135 Million
-2,474,633 Reduced 99.48%
12,960 $702,000
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $40 Million - $47.8 Million
825,614 Added 49.68%
2,487,593 $128 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $630,474 - $700,043
9,896 Added 0.6%
1,661,979 $106 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $98.3 Million - $112 Million
1,496,107 Added 959.19%
1,652,083 $115 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $8.56 Million - $10.1 Million
125,051 Added 404.37%
155,976 $11.2 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $40,929 - $24.2 Million
-314,845 Reduced 91.06%
30,925 $2.2 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $97.4 Million - $107 Million
-1,341,776 Reduced 79.51%
345,770 $26.6 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $112 Million - $134 Million
-1,819,552 Reduced 51.88%
1,687,546 $123 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $127 Million - $148 Million
2,370,388 Added 208.53%
3,507,098 $219 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $65.4 Million - $76.6 Million
-1,104,596 Reduced 49.28%
1,136,710 $67.3 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $38.9 Million - $42.3 Million
-627,710 Reduced 21.88%
2,241,306 $150 Million
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $3.55 Million - $3.99 Million
59,836 Added 2.13%
2,869,016 $181 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $89.1 Million - $101 Million
-1,543,208 Reduced 35.46%
2,809,180 $174 Million
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $80.5 Million - $89.2 Million
1,401,543 Added 47.5%
4,352,388 $262 Million
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $98.4 Million - $115 Million
1,795,182 Added 155.34%
2,950,845 $174 Million
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $40.5 Million - $58.9 Million
873,406 Added 309.44%
1,155,663 $64.4 Million
Q4 2019

Feb 14, 2020

SELL
$49.21 - $64.19 $6.86 Million - $8.94 Million
-139,343 Reduced 33.05%
282,257 $18.1 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $15.5 Million - $18.3 Million
-361,324 Reduced 46.15%
421,600 $21.4 Million
Q2 2019

Aug 15, 2019

BUY
$44.62 - $49.34 $26 Million - $28.8 Million
582,748 Added 291.12%
782,924 $35.5 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $228 Million - $253 Million
-5,120,459 Reduced 96.24%
200,176 $5.49 Million
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $84.9 Million - $101 Million
-1,882,341 Reduced 26.13%
5,320,635 $254 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $238 Million - $309 Million
4,890,444 Added 211.48%
7,202,976 $374 Million
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $96.9 Million - $109 Million
1,754,905 Added 314.71%
2,312,532 $144 Million
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $110 Million - $137 Million
-2,169,186 Reduced 79.55%
557,627 $30.9 Million
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $39.9 Million - $45.9 Million
665,890 Added 32.31%
2,726,813 $172 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $1.08 Million - $1.18 Million
18,064 Added 0.88%
2,060,923 $126 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $113 Million - $130 Million
2,042,859
2,042,859 $130 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.